Transcript Raal Lancet TESLA 2014 PACE

TESLA-B: mean change in LDL-c
levels with evolocumab or
placebo in patients with HoFH
Mean % change from baseline in
ultracentrifugation LDL cholesterol
Placebo group (n=16)
Evocolumab group (n=33)
Study week
Raal et al., The Lancet Oct 2014